Igor Makhlin, MD profile | PennMedicine.org
Igor Makhlin, MD Medical Oncology 5.0 with 393 ratings
Igor Makhlin, MD - Perelman School of Medicine at the University …
Igor Makhlin: Dissecting Biologic Risk Using Genomic Assays - Implications for Extended Endocrine Therapy and Beyond. JAMA Network Open - In Press. Lawrence Shulman (eds.). JAMA November 27 2024 Notes: In Press - publication date 11/27/24.
Dr. Igor Makhlin MD - US News Health
Dr. Igor Makhlin is a Oncologist in Philadelphia, PA. Find Dr. Makhlin's phone number, address, insurance information, hospital affiliations and more.
Dr. Igor Makhlin, MD - Medical Oncologist in Philadelphia, PA ...
Dr. Igor Makhlin, MD is a medical oncologist in Philadelphia, PA. He is affiliated with Hospital of the University of Pennsylvania. He is accepting telehealth appointments. Make an Appointment. Compare Dr. Makhlin with our nearby Medical Oncologists at …
Makhlin Evaluates Antibody-Drug Conjugate Trials in Metastatic …
2023年11月12日 · During a Targeted Oncology™ Case-Based Roundtable™ event, Igor Makhlin, MD, reviewed data from the TROPiCS-02 study of sacituzumab govitecan and the DESTINY-Breast04 study of trastuzumab deruxtecan in patients with metastatic breast cancer.
Dr. Igor Makhlin, MD, Oncology | Philadelphia, PA | WebMD
Dr. Igor Makhlin, MD, is an Oncology specialist practicing in Philadelphia, PA with 10 years of experience. This provider currently accepts 30 insurance plans including Medicare and Medicaid....
IGOR MAKHLIN MD - NPI 1457745689 - Internal Medicine in …
2015年3月25日 · This page provides the complete NPI Profile along with additional information for Igor Makhlin, an internist established in Philadelphia, Pennsylvania with a medical specialization in Internal Medicine and more than 10 years of experience.
Dr. Igor Makhlin, MD – Philadelphia, PA | Oncology - Doximity
Dr. Igor Makhlin, MD is an oncologist in Philadelphia, Pennsylvania. He is affiliated with Hospital of the University of Pennsylvania.
Dr. Igor Makhlin, MD, Medical Oncologist - Sharecare
Dr. Igor Makhlin, MD is a medical oncologist in Philadelphia, PA. He currently practices at Practice and is affiliated with Hospital of the University of Pennsylvania. He accepts multiple insurance plans. Dr. Makhlin is board certified in Internal Medicine.
Dato-DXd Shows Promise as a More Tolerable ADC in HER2 …
2024年7月22日 · During a Case-Based Roundtable® event, Igor Makhlin, MD, discussed with participants their impressions of datopotamab deruxtecan as therapy for patients with HR-positive, HER2-negative breast cancer, and the sequential use of multiple antibody-drug conjugates.